Vancouver-based Vanc Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter (OTC) markets, has been recognized in the 2016 TSX Venture 50 as the top performing Clean Technology & Life Sciences Company. The Company ranked number one in the sector. The 2016 TSX Venture 50™ is a ranking of strong performers on TSX Venture Exchange. These companies have shown results in key measures of market performance. The ranking is comprised of 10 companies from each of the five industry sectors, and they were selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume. On average, these companies have delivered a return of 77% in 2015. The shares of these companies also enjoy a liquid market, with a total of 3.0 billion shares trading over the course of 2015.
Click here for full release.